1103 related articles for article (PubMed ID: 15465079)
1. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
[TBL] [Abstract][Full Text] [Related]
3. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
4. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia.
Schellinger PD; Fiebach JB; Jansen O; Ringleb PA; Mohr A; Steiner T; Heiland S; Schwab S; Pohlers O; Ryssel H; Orakcioglu B; Sartor K; Hacke W
Ann Neurol; 2001 Apr; 49(4):460-9. PubMed ID: 11310623
[TBL] [Abstract][Full Text] [Related]
5. The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials.
Barber PA; Parsons MW; Desmond PM; Bennett DA; Donnan GA; Tress BM; Davis SM
J Neuroimaging; 2004 Apr; 14(2):123-32. PubMed ID: 15095557
[TBL] [Abstract][Full Text] [Related]
6. Evolution of lesion volume in acute stroke treated by intravenous t-PA.
Pialat JB; Wiart M; Nighoghossian N; Adeleine P; Derex L; Hermier M; Froment JC; Berthezene Y
J Magn Reson Imaging; 2005 Jul; 22(1):23-8. PubMed ID: 15971175
[TBL] [Abstract][Full Text] [Related]
7. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
8. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
9. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator.
Nighoghossian N; Hermier M; Adeleine P; Derex L; Dugor JF; Philippeau F; Ylmaz H; Honnorat J; Dardel P; Berthezène Y; Froment JC; Trouillas P
Stroke; 2003 Feb; 34(2):458-63. PubMed ID: 12574560
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of blood pressure variability after thrombolysis in acute stroke.
Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA
Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
[TBL] [Abstract][Full Text] [Related]
12. Association of pretreatment ASPECTS scores with tPA-induced arterial recanalization in acute middle cerebral artery occlusion.
Tsivgoulis G; Saqqur M; Sharma VK; Lao AY; Hoover SL; Alexandrov AV;
J Neuroimaging; 2008 Jan; 18(1):56-61. PubMed ID: 18190497
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
Kimura K; Iguchi Y; Yamashita S; Shibazaki K; Kobayashi K; Inoue T
J Neurol Sci; 2008 Apr; 267(1-2):57-61. PubMed ID: 17964602
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery.
Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y
J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647
[TBL] [Abstract][Full Text] [Related]
16. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging and clinical patterns of patients with 'spectacular shrinking deficit' after acute middle cerebral artery stroke.
Kraemer N; Thomalla G; Soennichsen J; Fiehler J; Knab R; Kucinski T; Zeumer H; Rother J
Cerebrovasc Dis; 2005; 20(5):285-90. PubMed ID: 16131796
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of evolution in acute middle cerebral artery infarction with perfusion-diffusion mismatch: atherosclerotic vs. cardioembolic occlusion.
Kim HJ; Yun SC; Cho KH; Cho AH; Kwon SU; Kim JS; Kang DW
J Neurol Sci; 2008 Oct; 273(1-2):93-8. PubMed ID: 18692854
[TBL] [Abstract][Full Text] [Related]
19. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA.
Ribo M; Molina CA; Delgado P; Rubiera M; Delgado-Mederos R; Rovira A; Munuera J; Alvarez-Sabin J
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
